Back
Matthews Emerging Markets Ex Chn Act ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
57
MEMX
Matthews Emerging Markets Ex Chn Act ETF
Last Price:
29.62
Seasonality Move:
8.21%
Buy
71
LBPH
Longboard Pharmaceuticals
Last Price:
59.76
Seasonality Move:
76.52%
Buy
57
Matthews Emerging Markets Ex Chn Act ETF (MEMX)
is a Buy
Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?
- The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.93. The Score for MEMX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MEMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $59.78. The Score for LBPH is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEMX Stock Price Chart
What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?
-
The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing selling pressure, which indicates risk of future bearish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $59.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing selling pressure, which indicates risk of future bearish movement.
MEMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 38.15 | Sell |
| Chaikin Money Flow: | -1315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.24 - 30.74) | Sell |
| Bollinger Bands (100): | (29.81 - 30.97) | Sell |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.63 | Buy |
| Relative Strength Index (14 RSI): | 80.51 | Buy |
| Chaikin Money Flow: | -417643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.61 - 64.55) | Buy |
| Bollinger Bands (100): | (27.56 - 49.76) | Buy |
MEMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.2 | Sell |
| 20-day SMA: | 30.46 | Sell |
| 50-day SMA: | 30.55 | Sell |
| 200-day SMA: | 29.59 | Buy |
| 8-day EMA: | 30.24 | Sell |
| 20-day EMA: | 30.39 | Sell |
| 50-day EMA: | 30.45 | Sell |
| 200-day EMA: | 29.51 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.72 | Buy |
| 20-day SMA: | 59.54 | Buy |
| 50-day SMA: | 44.08 | Buy |
| 200-day SMA: | 29.37 | Buy |
| 8-day EMA: | 59.56 | Buy |
| 20-day EMA: | 56.23 | Buy |
| 50-day EMA: | 47.87 | Buy |
| 200-day EMA: | 31.78 | Buy |
Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.46 per share.
Matthews Emerging Markets Ex Chn Act ETF Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||